This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: The Innovative Contributions of Bijan Andre Boldajipour
Introduction
Bijan Andre Boldajipour is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors (CARs) for cancer treatment. With a total of 3 patents, his work is paving the way for innovative therapeutic methods.
Latest Patents
One of his latest patents focuses on chimeric antigen receptors targeting B-cell maturation antigen (BCMA). This invention provides CARs that specifically bind to BCMA, which is crucial for the treatment of conditions associated with malignant cells expressing this antigen. The invention also encompasses engineered immune cells that incorporate these CARs, CAR-encoding nucleic acids, and methods for their production. Furthermore, it outlines therapeutic methods for utilizing these CARs and engineered immune cells in treating cancer.
Career Highlights
Bijan is currently associated with Pfizer Corporation, where he continues to advance his research and development efforts. His work is instrumental in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
He collaborates with talented individuals such as Tracy Chia-Chien Kuo and Javier Fernando Chaparro Riggers, contributing to a dynamic research environment that fosters innovation.
Conclusion
Bijan Andre Boldajipour's contributions to the field of biomedical engineering, particularly through his patents on CARs, highlight his role as a leading inventor in cancer treatment. His work at Pfizer Corporation and collaborations with esteemed colleagues further enhance the impact of his innovations.